XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)

Clinical trial NCT01178268 · COMPLETED

Trial details

NCT number: NCT01178268
Sponsor: Abbott Medical Devices
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Occlusion Thrombosis (Stent Thrombosis)Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis

Start date: 2010-08-01
Primary completion: 2012-10-01
Enrollment: 546

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.